Inventor · disambiguated record
Xuefei Tan
Also filed as: TAN XUEFEI
31 granted patents·24 pending applications·122 citations·filing 2001–2022
95Inventor score
Top patents by PatentIndex Score
55 records- 0195US7718683B2Triazolyl phenyl benzenesulfonamidesCHEMOCENTRYX INC·Filed 2007·Granted May 18, 2010·39 cites·4 claims
- 0289US10035804B2Spirodiamine derivatives as aldosterone synthase inhibitorsHOFFMANN LA ROCHE·Filed 2017·Granted Jul 31, 2018·10 cites·20 claims
- 0386US9695151B23,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Jul 4, 2017·6 cites·24 claims
- 0486US9695152B23,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Jul 4, 2017·6 cites·23 claims
- 0582US6696443B2Piperidine/piperazine-type inhibitors of p38 kinaseSCIOS INC·Filed 2001·Granted Feb 24, 2004·15 cites·54 claims
- 0681US9505742B23,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compoundsHOFFMANN LA ROCHE·Filed 2015·Granted Nov 29, 2016·4 cites·24 claims
- 0779US6821966B2Inhibitors of p38 kinaseSCIOS INC·Filed 2001·Granted Nov 23, 2004·12 cites·31 claims
- 0877US9856279B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·1 cites·26 claims
- 0977US9260408B2Dihydroquinoline-2-one derivativesAEBI JOHANNES·Filed 2012·Granted Feb 16, 2016·4 cites·43 claims
- 1077US8153818B2Triazolyl phenyl benzenesulfonamidesCHARVAT TREVOR T·Filed 2010·Granted Apr 10, 2012·3 cites·23 claims
- 1176US7214679B2Piperidine/piperazine-type inhibitors of p38 kinaseSCIOS INC·Filed 2004·Granted May 8, 2007·10 cites·20 claims
- 1273US9187429B2Phenyl-tetrahydroisoquinoline derivativesHOFFMANN LA ROCHE·Filed 2013·Granted Nov 17, 2015·2 cites·42 claims
- 1372US6890938B2Indole-type inhibitors of p38 kinaseSCIOS INC·Filed 2001·Granted May 10, 2005·6 cites·28 claims
- 1469US9662327B2Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancerCAO SHELDON·Filed 2012·Granted May 30, 2017·2 cites·22 claims
- 1569US8481579B2Triazolyl phenyl benzenesulfonamidesCHARVAT TREVOR T·Filed 2012·Granted Jul 9, 2013·1 cites·24 claims
- 1667US9353081B2Bicyclic dihydroquinoline-2-one derivativesAEBI JOHANNES·Filed 2012·Granted May 31, 2016·1 cites·21 claims
- 1759US2025011300A1Piperazinylsulfonylaryl compounds for treatment of bacterial infectionsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1857US2024417387A1Sulfonylpiperazinyl compounds for treatment of bacterial infectionsHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1957US2007185112A1Piperidine/piperazine-type inhibitors of p38 kinaseMAVUNKEL BABU·Filed 2007·Application pending·0 cites
- 2056US12012390B2Flavone compounds for the treatment and prophylaxis of hepatitis B virus diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Jun 18, 2024·0 cites·19 claims
- 2156US2023295109A1Pyridinone compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2256US2020339603A1Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 2355US2023279001A1Imidazo[1,2-a]pyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2455US2021221832A1Substituted pyridoindoles for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2554US7291613B2Inhibitors of p38 kinaseSCIOS INC·Filed 2004·Granted Nov 6, 2007·0 cites·22 claims
- 2654US2021317141A1Oxopyrido[1,2-a]pyrimidine compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2754US2021309657A1Tricyclic compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2854US2021309658A1Aryl compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2953US2021323981A1Free amino compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3051US11993591B2Chromen-4-one derivatives for the treatment and prophylaxis of hepatitis B virus diseaseHOFFMANN LA ROCHE·Filed 2019·Granted May 28, 2024·0 cites·2 claims
- 3151US2021238197A1Novel oxoquinolizine compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 3251US2022388969A1Substituted 3,4-dihydroquinazoline for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 3351US2022396567A1Substituted pyrimidine for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 3451US2022348549A1Quinazoline compounds for the treatment and prophylaxis of hepatitis b virus diseaseHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 3549US10662203B2Pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infectionHOFFMANN LA ROCHE·Filed 2018·Granted May 26, 2020·0 cites·27 claims
- 3649US10611748B2Xanthone derivatives for the treatment of hepatitis B virus diseaseHOFFMANN LA ROCHE·Filed 2018·Granted Apr 7, 2020·0 cites·31 claims
- 3749US2005171183A1Indole-type inhibitors of p38 kinaseSCIOS INC·Filed 2005·Application pending·0 cites
- 3848US2017210749A1Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3947US2022213049A1Substituted chromen-4-one for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 4046US2021387996A1Tricyclic compounds for the treatment and prophylaxis of hepatitis b virus diseaseHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 4145US2022169639A1N-containing chromen-4-one derivatives for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 4244US2022388972A1Chroman-4-one derivatives for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 4343US9464058B2Imidazolylketone derivativesHOFFMANN LA ROCHE·Filed 2013·Granted Oct 11, 2016·0 cites·17 claims
- 4443US2005288299A1Azaindole derivatives as inhibitors of p38 kinaseMAVUNKEL BABU J·Filed 2005·Application pending·0 cites
- 4543US2014213580A1Therapeutically active compositions and their methods of useCAO SHELDON·Filed 2012·Application pending·0 cites
- 4642US9790200B2Dihydroquinoline pyrazolyl compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Oct 17, 2017·0 cites·19 claims
- 4741US9796726B2Dihydroquinoline pyrazolyl compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Oct 24, 2017·0 cites·21 claims
- 4841US9796702B2Dihydroquinoline pyrazolyl compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Oct 24, 2017·0 cites·20 claims
- 4941US9133158B2Bicyclic dihydroisoquinoline-1-one derivativesHOFFMANN LA ROCHE·Filed 2012·Granted Sep 15, 2015·0 cites·56 claims
- 5040US9790217B2Pyridinyloxy- and phenyloxy-pyrazolyl compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Oct 17, 2017·0 cites·20 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Xuefei Tan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →